Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RJET
5001
Republic Airways Holdings
RJET
$967M
| $186K | ﹤0.01% |
1,387
+702
| +102% | +$81K |
|
5002
Reading International Class A
RDI
$33.2M
| $186K | ﹤0.01% |
16,644
+8,090
| +95% | +$90.3K |
|
5003
CALL
Chord Energy
CHRD
$7.9B
| $185K | ﹤0.01% |
56,800
-6,100
| -10% | -$17.5K |
|
5004
CorMedix
CRMD
$591M
| $185K | ﹤0.01% |
25,391
+13,501
| +114% | +$82.5K |
|
5005
PUT
Gold Fields
GFI
$29B
| $185K | ﹤0.01% |
28,100
+17,800
| +173% | +$101K |
|
5006
CALL
Icahn Enterprises
IEP
$5.24B
| $185K | ﹤0.01% |
3,000
-2,800
| -48% | -$181K |
|
5007
Stratus Properties
STRS
$156M
| $185K | ﹤0.01% |
5,983
+2,909
| +95% | +$83.4K |
|
5008
CALL
Terex
TEX
$7.18B
| $185K | ﹤0.01% |
6,200
-3,400
| -35% | -$95.6K |
|
5009
United States Lime & Minerals
USLM
$3.16B
| $185K | ﹤0.01% |
10,210
+4,125
| +68% | +$72.5K |
|
|
HOME
5010
CALL
DELISTED
At Home Group Inc.
HOME
| $185K | ﹤0.01% |
33,700
+14,795
| +78% | +$120K |
|
|
APHA
5011
PUT
DELISTED
Aphria Inc. Common Shares
APHA
| $185K | ﹤0.01% |
+35,500
| New | +$174K |
|
|
AMED
5012
PUT
DELISTED
Amedisys
AMED
| $184K | ﹤0.01% |
1,100
+1,000
| +1,000% | +$149K |
|
5013
CALL
Dine Brands
DIN
$456M
| $184K | ﹤0.01% |
2,200
-8,200
| -79% | -$637K |
|
5014
CALL
Fossil Group
FOSL
$293M
| $184K | ﹤0.01% |
23,300
+100
| +0.4% | +$922 |
|
5015
Northeast Bank
NBN
$1.06B
| $184K | ﹤0.01% |
8,370
+4,610
| +123% | +$102K |
|
5016
Rockwell Medical
RMTI
$28.4M
| $184K | ﹤0.01% |
685
+350
| +104% | +$88K |
|
5017
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.37B
| $183K | ﹤0.01% |
1,700
| – | – |
|
5018
C&F Financial
CFFI
$268M
| $183K | ﹤0.01% |
3,316
+1,655
| +100% | +$88.2K |
|
5019
Teucrium Corn Fund
CORN
$176M
| $183K | ﹤0.01% |
12,373
-16,006
| -56% | -$238K |
|
5020
Entravision Communication
EVC
$1.03B
| $183K | ﹤0.01% |
69,890
+30,194
| +76% | +$82.5K |
|
5021
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$337M
| $183K | ﹤0.01% |
138
-590
| -81% | -$909K |
|
|
SLCA
5022
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $183K | ﹤0.01% |
29,700
+5,600
| +23% | +$33.8K |
|
5023
PUT
SiriusXM
SIRI
$9.98B
| $181K | ﹤0.01% |
2,533
-1,020
| -29% | -$68.7K |
|
5024
PUT
Sanofi
SNY
$103B
| $181K | ﹤0.01% |
3,600
-2,000
| -36% | -$93.7K |
|
5025
PUT
Sunoco
SUN
$14.4B
| $181K | ﹤0.01% |
5,900
-400
| -6% | -$12.6K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.